Literature DB >> 20953848

Successful management of congenital chylous ascites in a premature infant using somatostatin analogue.

Yuefang Huang1, Siqi Zhuang, Yijuan Li, Meina Liu, Huiqing Chen, Minlian Du.   

Abstract

Congenital chylous ascites (CCA) is a rare disease defined as the accumulation of chylomicron-rich lymphatic fluid within the peritoneal cavity, resulting from maldevelopment of the intra-abdominal lymphatic system. Cases unresponsive to conservative treatment usually require surgical intervention. We report a case of CCA in a premature neonate, who was treated successfully with intravenous infusion of octreotide, a synthetic somatostatin analogue after failure to response to traditional supportive therapies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20953848     DOI: 10.1007/s12098-010-0256-1

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  9 in total

1.  Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in healthy volunteers.

Authors:  P Schiedermaier; K A Brensing; B Göke; T Schätzle; T Sauerbruch
Journal:  Digestion       Date:  1999 Mar-Apr       Impact factor: 3.216

2.  Octreotide in congenital chylous ascites an avoid requirement of total parenteral nutrition.

Authors:  Rakesh Mishra; Sanjeev Kumar
Journal:  Indian J Gastroenterol       Date:  2007 Nov-Dec

3.  Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin.

Authors:  J I Ulíbarri; Y Sanz; C Fuentes; A Mancha; M Aramendia; S Sánchez
Journal:  Lancet       Date:  1990-07-28       Impact factor: 79.321

4.  Successful treatment of congenital chylous ascites with a somatostatin analogue.

Authors:  M G Caty; M L Hilfiker; R G Azizkhan; P L Glick
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

5.  Intractable congenital chylous ascites.

Authors:  A B te Pas; K vd Ven; M P M Stokkel; F J Walther
Journal:  Acta Paediatr       Date:  2004-10       Impact factor: 2.299

6.  Octreotide-induced hypoxemia and pulmonary hypertension in premature neonates.

Authors:  R P Arevalo; P Bullabh; A N Krauss; P A M Auld; Nitsana Spigland
Journal:  J Pediatr Surg       Date:  2003-02       Impact factor: 2.545

7.  Aetiology and treatment of chylous ascites.

Authors:  N L Browse; N M Wilson; F Russo; H al-Hassan; D R Allen
Journal:  Br J Surg       Date:  1992-11       Impact factor: 6.939

Review 8.  Octreotide in the treatment of congenital chylothorax.

Authors:  S V Rasiah; J Oei; K Lui
Journal:  J Paediatr Child Health       Date:  2004 Sep-Oct       Impact factor: 1.954

9.  Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe?

Authors:  Hadi Mohseni-Bod; Duncan Macrae; Zdenek Slavik
Journal:  Pediatr Crit Care Med       Date:  2004-07       Impact factor: 3.624

  9 in total
  5 in total

1.  Successful management of congenital chylous ascites with early octreotide and total parenteral nutrition in a newborn.

Authors:  Claudio Olivieri; Lorenzo Nanni; Lucia Masini; Claudio Pintus
Journal:  BMJ Case Rep       Date:  2012-09-25

2.  Japanese clinical practice guidelines for vascular anomalies 2017.

Authors:  Hidefumi Mimura; Sadanori Akita; Akihiro Fujino; Masatoshi Jinnin; Mine Ozaki; Keigo Osuga; Hiroki Nakaoka; Eiichi Morii; Akira Kuramochi; Yoko Aoki; Yasunori Arai; Noriko Aramaki; Masanori Inoue; Yuki Iwashina; Tadashi Iwanaka; Shigeru Ueno; Akihiro Umezawa; Michio Ozeki; Junko Ochi; Yoshiaki Kinoshita; Masakazu Kurita; Shien Seike; Nobuyuki Takakura; Masataka Takahashi; Takao Tachibana; Kumiko Chuman; Shuji Nagata; Mitsunaga Narushima; Yasunari Niimi; Shunsuke Nosaka; Taiki Nozaki; Kazuki Hashimoto; Ayato Hayashi; Satoshi Hirakawa; Atsuko Fujikawa; Yumiko Hori; Kentaro Matsuoka; Hideki Mori; Yuki Yamamoto; Shunsuke Yuzuriha; Naoaki Rikihisa; Shoji Watanabe; Shinichi Watanabe; Tatsuo Kuroda; Shunsuke Sugawara; Kosuke Ishikawa; Satoru Sasaki
Journal:  Jpn J Radiol       Date:  2020-04       Impact factor: 2.374

3.  Japanese Clinical Practice Guidelines for Vascular Anomalies 2017.

Authors:  Hidefumi Mimura; Sadanori Akita; Akihiro Fujino; Masatoshi Jinnin; Mine Ozaki; Keigo Osuga; Hiroki Nakaoka; Eiichi Morii; Akira Kuramochi; Yoko Aoki; Yasunori Arai; Noriko Aramaki; Masanori Inoue; Yuki Iwashina; Tadashi Iwanaka; Shigeru Ueno; Akihiro Umezawa; Michio Ozeki; Junko Ochi; Yoshiaki Kinoshita; Masakazu Kurita; Shien Seike; Nobuyuki Takakura; Masataka Takahashi; Takao Tachibana; Kumiko Chuman; Shuji Nagata; Mitsunaga Narushima; Yasunari Niimi; Shunsuke Nosaka; Taiki Nozaki; Kazuki Hashimoto; Ayato Hayashi; Satoshi Hirakawa; Atsuko Fujikawa; Yumiko Hori; Kentaro Matsuoka; Hideki Mori; Yuki Yamamoto; Shunsuke Yuzuriha; Naoaki Rikihisa; Shoji Watanabe; Shinichi Watanabe; Tatsuo Kuroda; Shunsuke Sugawara; Kosuke Ishikawa; Satoru Sasaki
Journal:  J Dermatol       Date:  2020-03-22       Impact factor: 4.005

4.  Congenital chylous ascites.

Authors:  Justyna Romańska-Kita; Maria Katarzyna Borszewska-Kornacka; Anna Dobrzańska; Iwona Rudzińska; Justyna Czech-Kowalska; Tomasz Wawrzoniak
Journal:  Pol J Radiol       Date:  2011-07

5.  Congenital chylous ascites treated successfully with MCT-Based formula and octreotide.

Authors:  Radheshyam Purkait; Ashis Saha; Isita Tripathy; Birendranath Roy
Journal:  J Indian Assoc Pediatr Surg       Date:  2014-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.